Five Prime Therapeutics, Inc. (FPRX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
19-Apr-21 7:53 PM
View: 
Collins Helen Louise
EVP and Chief Medical Officer
Five Prime Therapeutics, Inc. (FPRX) 16-Apr-21Grant 66,000----95%
69.55K to 135.55K
19-Apr-21 8:04 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 16-Apr-21Disposition 2,385$38.00$90,630.00(100%)
2.38K to 0
19-Apr-21 8:04 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 16-Apr-21Grant 66,000----62%
105.85K to 171.85K
19-Apr-21 7:53 PM
View: 
Collins Helen Louise
EVP and Chief Medical Officer
Five Prime Therapeutics, Inc. (FPRX) 16-Apr-21Disposition 135,547$38.00$5,150,790.00(100%)
135.55K to 0
19-Apr-21 7:57 PM
View: 
Smith David V
Executive Vice President & CFO
Five Prime Therapeutics, Inc. (FPRX) 16-Apr-21Grant 66,000----90%
72.95K to 138.95K
19-Apr-21 7:49 PM
View: 
White David
See Remarks
Five Prime Therapeutics, Inc. (FPRX) 16-Apr-21Disposition 33,423$38.00$1,270,070.00(100%)
33.42K to 0
0%
19-Apr-21 7:21 PM
View: 
Civik Thomas
President and CEO
Director
Five Prime Therapeutics, Inc. (FPRX) 16-Apr-21Disposition 68,971$38.00$2,620,900.00(100%)
68.97K to 0
0%
19-Apr-21 8:04 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 16-Apr-21Disposition 169,468$38.00$6,439,780.00(99%)
171.85K to 2.38K
19-Apr-21 7:57 PM
View: 
Smith David V
Executive Vice President & CFO
Five Prime Therapeutics, Inc. (FPRX) 16-Apr-21Disposition 138,947$38.00$5,279,990.00(100%)
138.95K to 0
19-Apr-21 7:42 PM
View: 
Berger Franklin M
Director
Five Prime Therapeutics, Inc. (FPRX) 16-Apr-21Disposition 5,000$38.00$190,000.00(100%)
5.0K to 0
0%
13-Apr-21 1:05 PM
View: 
Civik Thomas
President and CEO
Director
Five Prime Therapeutics, Inc. (FPRX) 09-Apr-21Payment of Exercise 11,088$37.94$420,679.00(14%)
80.06K to 68.97K
(< 1%)
19-Apr-21 8:04 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 06-Apr-21Gift 14,174----(12%)
119.23K to 105.06K
19-Apr-21 7:46 PM
View: 
Ringo William R
Director
Five Prime Therapeutics, Inc. (FPRX) 05-Apr-21Gift 10,000----(100%)
10.0K to 0
19-Apr-21 8:04 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 05-Apr-21Gift 2,460----(2%)
121.69K to 119.23K
19-Apr-21 8:04 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 01-Apr-21Gift 2,385----2%
123.13K to 125.52K
19-Apr-21 8:04 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 01-Apr-21Gift 3,825----(3%)
125.52K to 121.69K
19-Apr-21 7:53 PM
View: 
Collins Helen Louise
EVP and Chief Medical Officer
Five Prime Therapeutics, Inc. (FPRX) 31-Mar-21Gift 8,085----(10%)
77.63K to 69.55K
02-Mar-21 12:00 PM
View: 
White David
See Remarks
Five Prime Therapeutics, Inc. (FPRX) 28-Feb-21Payment of Exercise 1,461$22.23$32,478.00(4%)
34.88K to 33.42K
(71%)
02-Mar-21 12:16 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 26-Feb-21Payment of Exercise 1,158$22.23$25,742.30(< 1%)
124.59K to 123.43K
(71%)
02-Mar-21 12:08 PM
View: 
Collins Helen Louise
EVP and Chief Medical Officer
Five Prime Therapeutics, Inc. (FPRX) 26-Feb-21Payment of Exercise 1,158$22.23$25,742.30(1%)
78.79K to 77.63K
(71%)
26-Feb-21 2:36 PM
View: 
Collins Helen Louise
EVP and Chief Medical Officer
Five Prime Therapeutics, Inc. (FPRX) 25-Feb-21Payment of Exercise 1,653$23.08$38,151.20(2%)
80.44K to 78.79K
(65%)
26-Feb-21 2:42 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 25-Feb-21Payment of Exercise 1,653$23.08$38,151.20(1%)
126.24K to 124.59K
(65%)
26-Feb-21 2:26 PM
View: 
White David
See Remarks
Five Prime Therapeutics, Inc. (FPRX) 24-Feb-21Payment of Exercise 1,155$25.71$29,695.00(3%)
36.04K to 34.88K
(48%)
26-Feb-21 2:36 PM
View: 
Collins Helen Louise
EVP and Chief Medical Officer
Five Prime Therapeutics, Inc. (FPRX) 24-Feb-21Payment of Exercise 5,091$25.71$130,890.00(6%)
85.53K to 80.44K
(48%)
26-Feb-21 2:31 PM
View: 
Smith David V
Executive Vice President & CFO
Five Prime Therapeutics, Inc. (FPRX) 24-Feb-21Payment of Exercise 5,110$25.71$131,378.00(7%)
78.06K to 72.95K
(48%)
26-Feb-21 2:42 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 24-Feb-21Payment of Exercise 5,100$25.71$131,121.00(4%)
131.34K to 126.24K
(48%)
15-Dec-20 12:19 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 11-Dec-20Option Exercise 22,000----19%
116.01K to 138.01K
15-Dec-20 12:00 PM
View: 
Collins Helen Louise
EVP and Chief Medical Officer
Five Prime Therapeutics, Inc. (FPRX) 11-Dec-20Payment of Exercise 11,583$16.14$186,950.00(12%)
97.12K to 85.53K
(135%)
15-Dec-20 12:09 PM
View: 
Smith David V
Executive Vice President & CFO
Five Prime Therapeutics, Inc. (FPRX) 11-Dec-20Payment of Exercise 11,504$16.14$185,675.00(13%)
89.56K to 78.06K
(135%)
15-Dec-20 12:19 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 11-Dec-20Payment of Exercise 11,583$16.14$186,950.00(8%)
138.01K to 126.43K
(135%)
15-Dec-20 12:00 PM
View: 
Collins Helen Louise
EVP and Chief Medical Officer
Five Prime Therapeutics, Inc. (FPRX) 11-Dec-20Option Exercise 22,000----29%
75.12K to 97.12K
15-Dec-20 12:09 PM
View: 
Smith David V
Executive Vice President & CFO
Five Prime Therapeutics, Inc. (FPRX) 11-Dec-20Option Exercise 22,000----33%
67.56K to 89.56K
30-Nov-20 2:49 PM
View: 
Smith David V
Executive Vice President & CFO
Five Prime Therapeutics, Inc. (FPRX) 26-Nov-20Payment of Exercise 6,920$18.45$127,674.00(9%)
74.48K to 67.56K
(106%)
13-Nov-20 12:38 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 11-Nov-20Payment of Exercise 11,001$18.00$198,018.00(9%)
127.01K to 116.01K
(111%)
13-Nov-20 12:17 PM
View: 
Ringo William R
Director
Five Prime Therapeutics, Inc. (FPRX) 11-Nov-20Option Exercise 78,959$2.41$190,369.00790%
10.0K to 88.96K
13-Nov-20 12:25 PM
View: 
Collins Helen Louise
EVP and Chief Medical Officer
Five Prime Therapeutics, Inc. (FPRX) 11-Nov-20Option Exercise 22,000----34%
64.16K to 86.16K
13-Nov-20 5:29 PM
View: 
Bvf Partners L P/il
Five Prime Therapeutics, Inc. (FPRX) 11-Nov-20Market Sale 7,393,340$20.19$149,247,008.00(86%)
8.63M to 1.24M
(88%)
13-Nov-20 12:29 PM
View: 
Smith David V
Executive Vice President & CFO
Five Prime Therapeutics, Inc. (FPRX) 11-Nov-20Payment of Exercise 10,908$18.00$196,344.00(13%)
85.39K to 74.48K
(111%)
13-Nov-20 12:29 PM
View: 
Smith David V
Executive Vice President & CFO
Five Prime Therapeutics, Inc. (FPRX) 11-Nov-20Option Exercise 22,000----35%
63.39K to 85.39K
13-Nov-20 12:38 PM
View: 
Sarena Francis Willard
Chief Strategy Officer
Five Prime Therapeutics, Inc. (FPRX) 11-Nov-20Option Exercise 22,000----21%
105.01K to 127.01K
13-Nov-20 12:25 PM
View: 
Collins Helen Louise
EVP and Chief Medical Officer
Five Prime Therapeutics, Inc. (FPRX) 11-Nov-20Payment of Exercise 11,039$18.00$198,702.00(13%)
86.16K to 75.12K
(111%)
13-Nov-20 12:17 PM
View: 
Ringo William R
Director
Five Prime Therapeutics, Inc. (FPRX) 11-Nov-20Market Option Sale (Planned) 78,959$22.50$1,776,580.00(89%)
88.96K to 10.0K
(69%)
06-Nov-20 6:30 PM
View: 
Bvf Partners L P/il
10% Owner
Five Prime Therapeutics, Inc. (FPRX) 06-Nov-20Market Purchase 30,000$4.98$149,520.00< 1%
8.6M to 8.63M
662%
06-Nov-20 6:30 PM
View: 
Bvf Partners L P/il
10% Owner
Five Prime Therapeutics, Inc. (FPRX) 04-Nov-20Market Purchase 416,562$4.88$2,034,570.005%
8.18M to 8.6M
678%
08-Oct-20 5:27 PM
View: 
Bvf Partners L P/il
10% Owner
Five Prime Therapeutics, Inc. (FPRX) 06-Oct-20Market Purchase 345,241$5.03$1,738,290.004%
7.84M to 8.18M
655%
02-Oct-20 1:51 PM
View: 
White David
See Remarks
Five Prime Therapeutics, Inc. (FPRX) 30-Sep-20Payment of Exercise 6,916$4.70$32,505.20(16%)
42.95K to 36.04K
(708%)
24-Sep-20 7:49 PM
View: 
Bvf Partners L P/il
10% Owner
Five Prime Therapeutics, Inc. (FPRX) 22-Sep-20Market Purchase 32$3.80$121.56< 1%
7.84M to 7.84M
900%
24-Aug-20 1:46 PM
View: 
Collins Helen Louise
EVP and Chief Medical Officer
Five Prime Therapeutics, Inc. (FPRX) 20-Aug-20Payment of Exercise 827$4.69$3,878.63(1%)
64.98K to 64.16K
(709%)
18-May-20 8:02 PM
View: 
Bvf Partners L P/il
10% Owner
Five Prime Therapeutics, Inc. (FPRX) 14-May-20Market Purchase 293,587$4.10$1,203,710.004%
7.55M to 7.84M
825%
14-Apr-20 4:38 PM
View: 
Civik Thomas
President and CEO
Director
Five Prime Therapeutics, Inc. (FPRX) 13-Apr-20Grant 75,000----100%
0 to 75.0K